Literature DB >> 16078120

Long-term outcome after surgical closure of atrial septal defect in childhood with extensive assessment including MRI measurement of the ventricles.

D Bolz1, T Lacina, P Buser, M Buser, J Guenthard.   

Abstract

Surgical closure of the secundum type of atrial septal defect (ASD) in childhood leads to excellent survival. However, relevant morbidity has been reported. Transcatheter closure of these defects has now become an alternative approach. To compare the results of the two different interventions, reliable data are needed on the long-term morbidity after defect closure with both methods. Patients were evaluated after a minimum of 10 years after surgical closure of an ASD in childhood. Assessment included analysis of perioperative data, interview, clinical examination, electrocardiogram, (ECG), 24-hour ECG, ergometry, chest radiograph, echocardiography, and MRI. A total of 66 patients underwent operation between 1971 and 1986 at our institution. Forty-eight of them (73%) were interviewed and 38 (58%) participated fully in the study program. Eighteen (27%) either refused to participate or were lost to follow-up. There were no substantial residual disorders, such as arrhythmias, right-sided heart dilatation, pulmonary hypertension, or reduced work capacity. Surgical closure of an ASD in childhood has an excellent long-term outcome. Surgical closure is thus the standard against which transcatheter closure needs to be measured.

Entities:  

Mesh:

Year:  2005        PMID: 16078120     DOI: 10.1007/s00246-005-0838-2

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  26 in total

1.  ATRIAL SEPTAL DEFECT WITH PULMONARY HYPERTENSION.

Authors:  E Besterman
Journal:  Br Heart J       Date:  1961-09

2.  Later results of closure of secundum atrial septal defect in children.

Authors:  D Young
Journal:  Am J Cardiol       Date:  1973-01       Impact factor: 2.778

3.  Arrhythmias after repair of secundum atrial septal defect: the influence of surgical modification.

Authors:  M T Bink-Boelkens; K J Meuzelaar; A Eygelaar
Journal:  Am Heart J       Date:  1988-03       Impact factor: 4.749

4.  Current outcomes of surgical closure of secundum atrial septal defect.

Authors:  J S Pastorek; H D Allen; J T Davis
Journal:  Am J Cardiol       Date:  1994-07-01       Impact factor: 2.778

5.  Responses of normal children and young adults to controlled bicycle exercise.

Authors:  F W James; S Kaplan; C J Glueck; J Y Tsay; M J Knight; C J Sarwar
Journal:  Circulation       Date:  1980-05       Impact factor: 29.690

6.  Cardiac arrhythmias following successful surgical closure of atrial septal defect.

Authors:  J M Reid; J C Stevenson
Journal:  Br Heart J       Date:  1967-09

7.  Developmental outcome after surgical versus interventional closure of secundum atrial septal defect in children.

Authors:  K J Visconti; D P Bichell; R A Jonas; J W Newburger; D C Bellinger
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

8.  Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years.

Authors:  J W Roos-Hesselink; F J Meijboom; S E C Spitaels; R van Domburg; E H M van Rijen; E M W J Utens; A J J C Bogers; M L Simoons
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

9.  Long-term follow-up of children after repair of atrial septal defects.

Authors:  J Mandelik; D S Moodie; R Sterba; D Murphy; E Rosenkranz; S Medendorp; A Kovaks
Journal:  Cleve Clin J Med       Date:  1994 Jan-Feb       Impact factor: 2.321

10.  25-year mortality after surgical repair of congenital heart defect in childhood. A population-based cohort study.

Authors:  C D Morris; V D Menashe
Journal:  JAMA       Date:  1991-12-25       Impact factor: 56.272

View more
  1 in total

1.  Lower Hospital Charges and Societal Costs for Catheter Device Closure of Atrial Septal Defects.

Authors:  Jessica N Sanchez; Michael D Seckeler
Journal:  Pediatr Cardiol       Date:  2017-07-05       Impact factor: 1.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.